<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04532580</url>
  </required_header>
  <id_info>
    <org_study_id>BCK-CEP</org_study_id>
    <nct_id>NCT04532580</nct_id>
  </id_info>
  <brief_title>Clinical Validation of Boneview for FDA Submission</brief_title>
  <official_title>Clinical Validation of Boneview for FDA Submission: Evaluation of the Ability of the Artificial Intelligence Software, Boneview, to Improve Physicians' and Radiologists' Performances in Detecting Fractures on Bone X-Rays Radiographs.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gleamer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gleamer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical validation is to assess comparative performances of physicians with&#xD;
      and without the assistance of BoneView for the diagnosis of fractures on radiographs.&#xD;
&#xD;
      The performances are evaluated in terms of accuracy (primary endpoint with the pair&#xD;
      specificity/sensitivity and the secondary endpoint PPV/NPV) and in terms of time needed for&#xD;
      diagnosis (secondary endpoint with the measurement of time on each case).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Actual">July 26, 2021</completion_date>
  <primary_completion_date type="Actual">May 10, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measurement of diagnosis performances via calculation of sensitivity, specificity, NPV, PPV</measure>
    <time_frame>1 month</time_frame>
    <description>calculation of sensitivity, specificity, NPV, PPV and comparison between the two cohorts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time needed for diagnosis via measurement of the time before submission of the diagnosis</measure>
    <time_frame>1 month</time_frame>
    <description>measurement of the time and comparison between the two cohorts</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">480</enrollment>
  <condition>Fracture</condition>
  <arm_group>
    <arm_group_label>AI- Aided performances</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>AI- Unaided performances</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Diagnosis of fracture on X-Ray Radiographs</intervention_name>
    <description>Diagnosis of fracture on X-Ray Radiographs with and without the assistance of Boneview Software</description>
    <arm_group_label>AI- Aided performances</arm_group_label>
    <arm_group_label>AI- Unaided performances</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The cases are consecutively sampled considering (non-)inclusion criteria (see below), and&#xD;
        following these constraints:&#xD;
&#xD;
          -  At least 60 exams for the foot/ankle region, 60 exams for the knee/leg region, 60&#xD;
             exams for the hip/pelvis region, 60 exams for the hand/wrist region, 60 exams for the&#xD;
             elbow/arm region, 60 exams for the shoulder/clavicula region, 60 exams of the rib cage&#xD;
             region, 60 exams of the dorsolumbar spine region&#xD;
&#xD;
          -  50% of exams of each region being positive: namely presenting one or multiple&#xD;
             fracture(s) and 50% of exams of each region being negative: namely presenting no&#xD;
             fracture&#xD;
&#xD;
          -  50% of positive exams of each anatomical region presenting at least a &quot;non-obvious&quot;&#xD;
             fracture and 50% with only &quot;obvious&quot; fracture(s). The determination of the &quot;obvious&quot;&#xD;
             and &quot;non-obvious&quot; nature of the fractures would be determined during the Ground Truth&#xD;
             determination process. The two osteo-articular experts that are performing the Ground&#xD;
             Truth have to state the nature of the fracture.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Anonymized standard X-ray exams of extremity/pelvis/rib cage/dorsolumbar spine not&#xD;
             containing or containing fracture(s).&#xD;
&#xD;
          -  Adult patient, with minimum age of 21 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exams with one or more images including a body part not concerned by the intended use&#xD;
             of BoneView (skull and cervical spine)&#xD;
&#xD;
          -  Cases with one or more images being used for model design and development.&#xD;
&#xD;
          -  Exams with one or more images being of poor quality (lossy), which prevent a proper&#xD;
             interpretation by the readers.&#xD;
&#xD;
          -  Cases not containing a medically relevant number of views for correct diagnosis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nor-Eddine Regnard, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Gleamer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Imaging Core Lab</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 25, 2020</study_first_submitted>
  <study_first_submitted_qc>August 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2020</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fracture</keyword>
  <keyword>artificial intelligence</keyword>
  <keyword>x-rays radiographs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no sharing of our IPD</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

